Alveo Technologies specializes in molecular detection platforms designed for early and actionable pathogen detection, aiming to secure global health and prevent future pandemics. The company operates in the healthcare, agriculture, and environmental sectors, serving clients ranging from healthcare providers to agricultural businesses. Alveo's business model revolves around providing handheld diagnostic tools that bring molecular detection out of the lab and into the field, making early pathogen detection accessible at the point of need. Revenue is generated through the sale of these diagnostic devices and partnerships for co-developing assays on their open platform. Alveo's commitment to equitable access to accurate diagnostics drives its mission to positively impact communities worldwide.

Keywords: molecular detection, pathogen detection, handheld diagnostics, healthcare, agriculture, environmental health, early detection, point of care, equitable access, global health.